Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives.

F1000Research
Shawn GoyalDonald R Branch

Abstract

There continues to be no approved drugs for the treatment of Ebola virus disease (EVD). Despite a number of candidate drugs showing limited efficacy in vitro and/or in non-human primate studies, EVD continues to plaque certain areas of Africa without any efficacious treatments yet available. Recently, we have been exploring the potential for anti-malarial drugs to inhibit an in vitro model of Ebola Zaire replication using a transcription-competent virus-like particle (trVLP) assay. We examined the efficacy of chloroquine, amodiaquine and 36 novel anti-parasite quinoline derivatives at inhibiting Ebola virus replication. Drug efficacy was tested by trVLP assay and toxicity by MTT assay. Both chloroquine and amodiaquine were effective for inhibition of Ebola virus replication without significant toxicity. The half-maximal inhibitory concentration (IC 50) of chloroquine and amodiaquine to inhibit Ebola virus replication were IC 50, Chl = 3.95 µM and IC 50, Amo = 1.45 µM, respectively. Additionally, three novel quinoline derivatives were identified as having inhibitory activity and low toxicity for Ebola trVLP replication, with 2NH2Q being the most promising derivative, with an IC 50 of 4.66 µM. Quinoline compounds offer many advan...Continue Reading

References

Dec 25, 2002·Emerging Infectious Diseases·Daniel T HaydonM Karen Laurenson
Mar 6, 2003·Bioorganic & Medicinal Chemistry Letters·Alain FournetBruno Figadère
Apr 28, 2004·Bioorganic & Medicinal Chemistry Letters·Christophe BénardJean d'Angelo
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Hector NakayamaAlain Fournet
Mar 16, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H NakayamaP M Loiseau
Jan 12, 2011·Antimicrobial Agents and Chemotherapy·Philippe M LoiseauDidier Desmaele
Mar 20, 2015·F1000Research·Sean Ekins, Megan Coffee
May 12, 2015·Annals of Global Health·Suresh Rewar, Dashrath Mirdha
Jan 7, 2016·The New England Journal of Medicine·Etienne GignouxIza Ciglenecki
Dec 26, 2016·Virology·Valerie Le SageAndrew J Mouland
Apr 12, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Cordelia E M ColtartDavid L Heymann
May 2, 2017·Current Opinion in Virology·Donata Medaglini, Claire-Anne Siegrist
Jun 3, 2017·Methods in Molecular Biology·Nadine Biedenkopf, Thomas Hoenen

❮ Previous
Next ❯

Citations

Dec 23, 2021·Expert Opinion on Drug Discovery·Ashfaq Ur RehmanJian Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
transfections
Transfection
Assay

Software Mentioned

Excel

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Clinical and Experimental Vaccine Research
Woonsung NaDaesub Song
Infectious Diseases and Therapy
Miguel J MartínezPaul E Kilgore
Relevé épidémiologique Hebdomadaire
BMJ : British Medical Journal
D Bennett, D Brown
JEMS : a Journal of Emergency Medical Services
James F Goss, Cynthia H Goss
© 2022 Meta ULC. All rights reserved